Agrn was found to be significantly upregulated in LPS-treated animals (Figure 4E), and previous work has found Agrn to be overexpressed in lung adenocarcinoma and to promote lung cancer progression [46]. The gene discussed is AGRN; the disease is lung carcinoma.